Please use this identifier to cite or link to this item:
|Title:||Genetic affinity and the right to ‘three-parent IVF’||Authors:||Schaefer G.O.
|Keywords:||Assisted human reproduction
Mitochondrial replacement therapy
|Issue Date:||2017||Publisher:||Springer New York LLC||Citation:||Schaefer G.O., Labude M.K. (2017). Genetic affinity and the right to ‘three-parent IVF’. Journal of Assisted Reproduction and Genetics 34 (12) : 1577-1580. ScholarBank@NUS Repository. https://doi.org/10.1007/s10815-017-1046-8||Abstract:||With the recent report of a live birth after use of mitochondrial replacement therapy, sometimes called ‘three-parent IVF’, the clinical application of the technique is fast becoming a reality. While the United Kingdom allows the procedure under regulatory scrutiny, it remains effectively outlawed in many other countries. We argue that such prohibitions may violate individuals’ procreative rights, grounded in individuals’ interest in genetic affinity. The interest in genetic affinity was recently endorsed by Singapore’s highest court, reflecting an emphasis on the importance of biological ties found across the globe. We apply that reasoning to make the case for a right to ‘three-parent IVF’. © 2017, Springer Science+Business Media, LLC.||Source Title:||Journal of Assisted Reproduction and Genetics||URI:||https://scholarbank.nus.edu.sg/handle/10635/156593||ISSN:||10580468||DOI:||10.1007/s10815-017-1046-8|
|Appears in Collections:||Elements|
Show full item record
Files in This Item:
|Genetic affinity and the right.docx||41.7 kB||Microsoft Word XML|
checked on Aug 20, 2019
checked on Aug 22, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.